Documente Academic
Documente Profesional
Documente Cultură
Nueva estrategia de
rehabilitacin del lenguaje
en la enfermedad de Parkinson
Torres Carro O,1 Alvarez L,2 Maragoto C,3 Alvarez E.4
RESUMEN
A pesar del desarrollo de nuevos frmacos y de las novedosas tcnicas quirrgicas, se hace imprescindible contar con un
sistema de rehabilitacin eficaz para los pacientes con EPI, ya que el incremento de la expectativa de vida y del tiempo
de evolucin de la enfermedad as lo requiere. Con una muestra de 100 pacientes, 50 de ellos recibieron el tratamiento
logopdico tradicional y al resto se le aplic el nuevo sistema teraputico grupal, durante 28 das con una frecuencia de
una hora diaria. Parkinsons disease, groupal speech rehabilitation. Pudimos constatar al culminar el estudio que el grupo
de pacientes que recibi la nueva estrategia obtuvo un porcentaje de mejora significativamente mayor, en especial en
las alteraciones articulares, seguida de las fonticas y por ltimo las prosdicas.
Palabras clave: Enfermedad de Parkinson, rehabilitacin de lenguaje en grupo.
Rev Mex Neuroci 2003; 4(5): 313-317
ABSTRACT
Instead of the development of new medication and surgical techniques, it is necessary to have an efficient rehabilitation
system for IPD patients. Fifty patients received the conventional logopedic treatment and 50 patients were submitted
to the groupal treatment in daily one-hour-sessions during 28 days. The percentage of improvement was higher in the
second group.
Key words: Parkinsons disease, groupal speech rehabilitation.
Rev Mex Neuroci 2003; 4(5): 313-317
Tabla 2.
Caractersticas de las alteraciones del lenguaje N =100.
Hipofona 25 48 23 96
Monotona 24 46 23 93
Vocalizacin 21 42 23 86
Resonancia 20 42 23 85
Prosodia 20 36 23 79
Articulacin 20 38 23 81
Tabla 4
Mejora [%]
Convencional Grupal Diferencia
Tabla 6
Tabla comparativa (alteraciones tpicas). Terapia convencional y grupal
Mejora [%]
Convencional Grupal Diferencia
REFERENCIAS 10. Metter EJ, Hanson WR. Clinical and acoustical variability
1. Atarachi J, Uchida E. A clinical study of Parkinsonism. in hypokinetic dysarthria. J Commun Dis 1986; 19: 347-66.
Recent Adv Res Nerv Syst 1959; 3: 871-82. 11. Oxtoby M. Parkinsons disease, patients and their social
2. Berry WR. Treatment of hypokinetic dysarthria. In: Perkins needs. London: Parkinson disease Society; 1982.
WH (ed.). Dysarthria and apraxia. New York: Thieme- 12. Raming LA. The role of phonation in speech intelligibility:
Stratton; 1983, p. 91-100. A review and preliminary data from patients with
3. Canter GJ. Speech characteristic of patients with Parkinsons Parkinsons disease. In: Kent R. (ed.). Intelligibility in speech
disease: II. Physiological support for speech. J Speech Hear disorders: theory, measurement and management.
Res 1965; 30: 44-9. Amsterdam: John Benjamin (in press).
4. Darley FL, Aronson AE, Brown JR. Cluster of deviant speech 13. Raming LA, Mead CL, DeSanto L. Voice therapy and Parkinsons
dimensions in the dysarthrias. J Speech Hear Res 1969; 12: disease. Am Speech Hear Assoc 1988; 30 (310): 128.
462-9. 14. Robertson SJ, Thompson F. Seepch therapy in Parkinson
5. De la Torre R, Mier M, Boshes B. Studies in parkisonism: disease: a study of the efficacy and long-term effects of
evaluation of respiratory function-preliminary observations. intensive treatment. Br J Disord Commun 1984; 19: 213-24.
Q Bull Northwest Univ Med School 1960; 34: 232-6. 15. Rubow R, Swift E. A microcomputer-based wearable
6. Hanson W, Metter E. DAF speech rate modification in biofeedback device to improve transfer of treatment in
Parkinsons disease: a report of two cases. In: Berry WR. parkinsonian dysarthria. J Speech Hear Disord 1985; 50:
(ed.). Clinical dysarthria. San Diego: College-Hill Press; 1983, 178-85.
p. 231-52. 16. Sarno MT. Speech impairment in Parkinsons disease. Arch
7. Hanson W, Metter E. DAF as instrumental treatment of Phys Med Rehab 1968; 49: 269-75.
dysarthrias in progressive supranuclear palsy: a case report. 17. Scott S, Caird FI, Williams BO. Communication in
J Speech Hear Disord 1980; 45: 268-76. Parkinsons disease. Rockville, Maryland: Aspen; 1985.
8. Hoodin RB, Gilbert HR. Nasal airflows in parkinsonian 18. Scott S, Caird FI. Speech therapy for Parkinsons disease. J
speakers. J Commun Dis 1989; 22: 169-80. Neurol Neurosurg Psychiatry 1983; 46: 1409d-144.
9. Koller WC. Dysfluency (stuttering) in extrapyramidal 19. Scott S, Caird FI. Speech therapy for patients with Parkinson
disease. Arch Neurol 1983; 40: 175- 7. disease. Br Med J 1981; 283: 1088.